Celanese (CE) Asset Writedowns and Impairment (2010 - 2025)

Celanese (CE) has 13 years of Asset Writedowns and Impairment data on file, last reported at $27.0 million in Q4 2025.

• Quarterly Asset Writedowns and Impairment fell 98.31% year-over-year to $27.0 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $3.1 billion (up 91.31% YoY) and the FY2025 annual result came in at $1.5 billion, down 7.69% from the prior year.
• Asset Writedowns and Impairment retreated to $27.0 million in Q4 2025, from $1.5 billion in the prior quarter.
• In the past five years, Asset Writedowns and Impairment ranged from a high of $1.6 billion in Q4 2024 to a low of $1.0 million in Q1 2021.
• A 5-year average of $265.4 million and a median of $7.5 million in 2023 frame the typical range for Asset Writedowns and Impairment.
• Annual changes were most pronounced in 2024 — Asset Writedowns and Impairment surged 26566.67% — and 2025, when it sank 98.31%.
• Tracing CE's Asset Writedowns and Impairment over 5 years: stood at $2.0 million in 2021, then changed by 0.0% to $2.0 million in 2022, then surged by 200.0% to $6.0 million in 2023, then surged by 26566.67% to $1.6 billion in 2024, then slumped by 98.31% to $27.0 million in 2025.
• The last three Asset Writedowns and Impairment figures came in at $27.0 million (Q4 2025), $1.5 billion (Q3 2025), and $1.6 billion (Q4 2024), per Business Quant data.